...
首页> 外文期刊>Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer >Effect of single doses of IV palonosetron, up to 2.25 mg, on the QTc interval duration: a double-blind, randomized, parallel group study in healthy volunteers
【24h】

Effect of single doses of IV palonosetron, up to 2.25 mg, on the QTc interval duration: a double-blind, randomized, parallel group study in healthy volunteers

机译:单剂量IV帕洛诺司琼(高达2.25 mg)对QTc间隔持续时间的影响:健康志愿者的双盲,随机,平行分组研究

获取原文
获取原文并翻译 | 示例
           

摘要

The use of serotonin type 3 (5-HT3) receptor antagonists (RAs) in the prevention of nausea and vomiting caused by emetogenic chemotherapy is part of a comprehensive management strategy for patients undergoing chemotherapy. Electrocardiographic effects have been reported in patients after intravenous administration of 5-HT3 RAs. The present study investigated the electrocardiogram (ECG) profile of the 5-HT3 RA palonosetron following International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) E14 Guidelines.
机译:使用3型血清素(5-HT3)受体拮抗剂(RAs)预防由致癌化学疗法引起的恶心和呕吐是接受化疗的患者全面治疗策略的一部分。静脉注射5-HT3 RA后,已有患者心电图报道。本研究在国际人用药品注册技术要求(ICH)E14指导原则国际会议之后调查了5-HT3 RA帕洛诺司琼的心电图(ECG)曲线。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号